Lybrate Logo
Get the App
For Doctors
Login/Sign-up
tab_logos
About
tab_logos
Feed
Overview

Inlyta 5Mg Tablet

Manufacturer :  Pfizer Ltd
Medicine Composition :  Axitinib
Prescription vs OTC : Prescription by Doctor required

About Inlyta 5Mg Tablet

Inlyta 5Mg Tablet is used to treat patients suffering from kidney cancer, when previous treatments to stop the disease have failed or are no longer working. Inlyta 5Mg Tablet is a tyrosine kinase inhibitor, and works by blocking specific substances in the body that cause the growth and multiplication of cancer cells.

Do not use Inlyta 5Mg Tablet if you are allergic to any of the ingredients present in Inlyta 5Mg Tablet, or if you have a case of recent bleeding in the bowels of the stomach. Before using Inlyta 5Mg Tablet tell your doctor if you are pregnant and/or breastfeeding, if you are using any prescription drugs, non-prescription drugs, or other herbal and dietary pills and supplements, if you are allergic to certain food items or substances, if you have thyroid or kidney or liver problems, if you have high blood pressure, if you have a history of stomach problems, if you have a history of heart diseases, or if you take medicines for high blood pressure.

Inlyta 5Mg Tablet is administered in the form of oral tablets, which should be taken as prescribed by the doctor.

Common side effects of Inlyta 5Mg Tablet include bleeding gums, stomach or abdominal pain, blurred vision, confusion, constipation, decreased urination, dry mouth and lightheadedness.

    Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

    What are the uses of Inlyta 5Mg Tablet

    • Kidney Cancer

    Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

    What are the side effects of Inlyta 5Mg Tablet ?

    • Headache

    • Nausea

    • Rash

    • Breathing Difficulty

    • Joint Pain

    • Difficulty In Speaking

    • Decreased Level Of Thyroid Hormones

    • Pain In Extremity

    • Haemorrhage

    • Vomiting

    • Abdominal Pain

    • Dyspepsia

    • Dry Skin

    • Diarrhoea

    • Increased Blood Pressure

    • Decreased Appetite

    • Cough

    • Altered Taste

    • Hand-Foot Syndrome

    • Constipation

    • Stomatitis (Inflammation Of The Mouth)

    • Protein In Urine

    Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

    Key highlights of Inlyta 5Mg Tablet

    • Is It safe with alcohol?

      Interaction with alcohol is unknown. Please consult your doctor.

    • Are there any pregnancy warnings?

      Inlyta 5mg tablet is unsafe to use during pregnancy.
      There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

    • Are there any breast-feeding warnings?

      Inlyta 5mg tablet is probably unsafe to use during breastfeeding. Please consult your doctor.

    • Is it safe to drive while on this medicine?

      Patients should be advised that they may experience events such as dizziness and/or fatigue during treatment with axitinib.

    • Does this affect kidney function?

      There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

    • Does this affect liver function?

      There is no data available. Please consult doctor before consuming the drug.

    Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

    How does this medication work?

    This medicine is used in the treatment of advanced kidney cancer. It judiciously inhibits the tyrosine kinase receptors VEGFR-1, which is the vascular endothelial growth factor receptor, VEGFR-2, and VEGFR-3, thereby halting the multiplication of cancer.

      Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

      Disclaimer : The information produced here is best of our knowledge and experience and we have tried our best to make it as accurate and up-to-date as possible, but we would like to request that it should not be treated as a substitute for professional advice, diagnosis or treatment.

      Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.

      Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.
      swan-banner
      Sponsored

      Popular Questions & Answers

      View All

      I (male) am 75 years old ,i have along Cancer s...

      related_content_doctor

      Dr. Nikhilesh Borkar

      Oncologist

      Axitinib is a tyrosine kinase inhibitor used in advanced or metastatic kidney cancer. If the canc...